osimertinib
astrazeneca
['nsclc', 'sclc', 'osimertinib']
outstanding results at #asco23 plenary, with concurrent publication. adjuvant osimertinib is currently available and reimbursed in . must ensure comprehensive ngs testing in all early stage non-squamous nsclc. 
Associate Professor and Medical Oncologist at University of Ottawa, Past President of Lung Cancer Canada, and a cricket fan!